Eli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in the U.S., selecting Houston as home to a $6.5 billion plant that will ...

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...

The global pharmaceutical industry is witnessing a steady transformation as plant-based active pharmaceutical ingredients (APIs) move from complementary roles toward becoming core components in modern ...

The project, approved in 2008, was meant to anchor the industry’s next phase of growth. Nearly two decades later, the site remains largely idle ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into funding the process through June 2024. Meanwhile, Phlow grew its analytical ...

AstraZeneca has commenced construction of its $4.5bn active pharmaceutical ingredient (API) manufacturing facility in Virginia. The site, which is located near Charlottesville, will produce APIs for ...

NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago ...

Houston plant to make inputs for orforglipron, other advanced therapies CEO David Ricks says new plant to be major hub for orforglipron, with some production at new Indiana site Houston plant to ...

A rendering of the $5 billion manufacturing facility that Eli LIlly plans to build in Virginia's Goochland County near Richmond. The planned manufacturing plant will be the company's first-ever ...

New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines Facility expected to be fully operational and serving patients by ...